DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID ▲ | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1292769 | Precursor B-cell lymphoblastic leukemia | CD44 | 960 | CD44 molecule (Indian blood group) | P16070 |
C1292769 | Precursor B-cell lymphoblastic leukemia | NAMPT | 10135 | nicotinamide phosphoribosyltransferase | P43490 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PIK3CA | 5290 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | P42336 |
C1292769 | Precursor B-cell lymphoblastic leukemia | BST1 | 683 | bone marrow stromal cell antigen 1 | Q10588 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C1292769 | Precursor B-cell lymphoblastic leukemia | IL18R1 | 8809 | interleukin 18 receptor 1 | Q13478 |
C1292769 | Precursor B-cell lymphoblastic leukemia | FCN2 | 2220 | ficolin 2 | Q15485 |
C1292769 | Precursor B-cell lymphoblastic leukemia | ALOX5 | 240 | arachidonate 5-lipoxygenase | P09917 |
C1292769 | Precursor B-cell lymphoblastic leukemia | CEACAM6 | 4680 | CEA cell adhesion molecule 6 | P40199 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PIK3CB | 5291 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | P42338 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PIK3CG | 5294 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | P48736 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PIP4K2A | 5305 | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | P48426 |
C1292769 | Precursor B-cell lymphoblastic leukemia | PTEN | 5728 | phosphatase and tensin homolog | P60484 |
C1292769 | Precursor B-cell lymphoblastic leukemia | SOAT1 | 6646 | sterol O-acyltransferase 1 | P35610 |
C1292769 | Precursor B-cell lymphoblastic leukemia | BST2 | 684 | bone marrow stromal cell antigen 2 | Q10589 |
C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | G6PD | 2539 | glucose-6-phosphate dehydrogenase | P11413 |
C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | ETNK1 | 55500 | ethanolamine kinase 1 | Q9HBU6 |
C1292777 | Aggressive natural killer-cell leukemia | B3GAT1 | 27087 | beta-1,3-glucuronyltransferase 1 | Q9P2W7 |
C1292777 | Aggressive natural killer-cell leukemia | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C1292777 | Aggressive natural killer-cell leukemia | FCGR3B | 2215 | Fc fragment of IgG receptor IIIb | O75015 |
C1292777 | Aggressive natural killer-cell leukemia | NCAM1 | 4684 | neural cell adhesion molecule 1 | P13591 |
C1292777 | Aggressive natural killer-cell leukemia | KLRB1 | 3820 | killer cell lectin like receptor B1 | Q12918 |
C1292777 | Aggressive natural killer-cell leukemia | SOAT1 | 6646 | sterol O-acyltransferase 1 | P35610 |
C1292778 | Chronic myeloproliferative disorder | FUT1 | 2523 | fucosyltransferase 1 (H blood group) | P19526 |
C1292778 | Chronic myeloproliferative disorder | FUT4 | 2526 | fucosyltransferase 4 | P22083 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024